Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 4:35 AM
Ignite Modification Date:
2025-12-26 @ 3:37 AM
NCT ID:
NCT00931918
Pre Assignment Details:
Participants with a diagnosis of Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma were enrolled equally in 1 of 2 treatment groups: RCHOP \[rituximab, cyclophosphamide, doxorubicin, prednisone\] or Vc-RCHOP \[bortezomib (VELCADE®), rituximab, cyclophosphamide, doxorubicin, prednisone\] for 6, 21 day cycles.
Recruitment Details:
Participants took part in the study at 69 investigative sites in the United States from 13 October 2009 to 15 August 2015.
Study:
NCT00931918
Study Brief:
Results Section:
NCT00931918